Literature DB >> 26550380

Analysis on correlation of white matter lesion and lacunar infarction with vascular cognitive impairment.

Ting Yan1, Jia-Rui Yu1, Yun-Pei Zhang1, Tao Li2.   

Abstract

OBJECTIVE: To investigate the correlation of white matter lesion (WML) and lacunar infarction (LI) with vascular cognitive impairment. To investigate the correlation of cognitive changes of vascular dementia (VD) patients with lacunar infarction (LI) and white matter lesion (WML).
METHODS: The clinical data of 60 cases of VD patients were evaluated and analyzed by combining with imageological findings and cognitive function assessment.
RESULTS: Multiple LI and WML were negatively correlated with both mini-mental state examination (MMSE) scale scores (r = -0.401, P = 0.036) and clock drawing test (CDT) scale scores (r = -0.482, P = 0.028); the LI number in occipital lobe was negatively correlated with MMSE scores (r = 0.338, P = 0.048), the LI number in temporal lobe was negatively correlated with CDT scores (r = -0.235, P = 0.047), and the LI number in frontal lobe was negatively correlated with MoCA scores (r = -0.450, P = 0.039).
CONCLUSION: All of LI location and number as well as WML are independent influencing factors of cognitive impairment of VD patients.

Entities:  

Keywords:  White matter lesion; multiple lacunar infarction; vascular cognitive impairment

Year:  2015        PMID: 26550380      PMCID: PMC4613065     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  11 in total

1.  Mitochondrial bioenergetic deficits in the hippocampi of rats with chronic ischemia-induced vascular dementia.

Authors:  J Du; M Ma; Q Zhao; L Fang; J Chang; Y Wang; R Fei; X Song
Journal:  Neuroscience       Date:  2012-12-08       Impact factor: 3.590

2.  The central histamine level in rat model of vascular dementia.

Authors:  A Stasiak; M Mussur; M Unzeta; D Lazewska; K Kiec-Kononowicz; W A Fogel
Journal:  J Physiol Pharmacol       Date:  2011-10       Impact factor: 3.011

3.  Functions of intronic nucleotide variants in the gene encoding pleckstrin homology like domain beta 2 (PHLDB2) on susceptibility to vascular dementia.

Authors:  Sangmi Eom; Chaeyoung Lee
Journal:  World J Biol Psychiatry       Date:  2011-11-23       Impact factor: 4.132

4.  Vascular dementia.

Authors:  Ae Young Lee
Journal:  Chonnam Med J       Date:  2011-08-31

5.  Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease.

Authors:  Maria Bjerke; Henrik Zetterberg; Åke Edman; Kaj Blennow; Anders Wallin; Ulf Andreasson
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  Vascular dementia: clinical and neuroradiological correlation.

Authors:  Dusko Racić; Petar Slankamenac; Zoran Vujković; Sinisa Miljković; Vlado Dajić; Aleksandra Dominović Kovacević
Journal:  Med Pregl       Date:  2011 Mar-Apr

7.  Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats.

Authors:  Bhupesh Sharma; Nirmal Singh
Journal:  Pharmacol Biochem Behav       Date:  2011-08-27       Impact factor: 3.533

8.  Associations between sex hormones and cognitive and neuropsychiatric manifestations in vascular dementia (VaD).

Authors:  Yi Xing; Wei Qin; Fang Li; Xiang-Fei Jia; Jianping Jia
Journal:  Arch Gerontol Geriatr       Date:  2012-10-24       Impact factor: 3.250

9.  Differential cholinergic pathway involvement in Alzheimer's disease and subcortical ischemic vascular dementia.

Authors:  Hee-Jin Kim; Won-Jin Moon; Seol-Heui Han
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  Oral disease in relation to future risk of dementia and cognitive decline: prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial.

Authors:  G-D Batty; Q Li; R Huxley; S Zoungas; B-A Taylor; B Neal; B de Galan; M Woodward; S-B Harrap; S Colagiuri; A Patel; J Chalmers
Journal:  Eur Psychiatry       Date:  2011-10-02       Impact factor: 5.361

View more
  6 in total

1.  The montreal cognitive assessment and mini-mental state examination visuoexecutive subtests in acute ischemic stroke patients and their correlations with demographic and clinical factors.

Authors:  Wei Wang; Fang-Ming Dong; Kai Shao; Shang-Zun Guo; Zhong-Min Zhao; Yi-Ming Yang; Ya-Xue Song; Jian-Hua Wang
Journal:  Acta Neurol Belg       Date:  2020-11-21       Impact factor: 2.396

2.  Is the time ripe for new diagnostic criteria of cognitive impairment due to cerebrovascular disease? Consensus report of the International Congress on Vascular Dementia working group.

Authors:  Robert Perneczky; Oren Tene; Johannes Attems; Panteleimon Giannakopoulos; M Arfan Ikram; Antonio Federico; Marie Sarazin; Lefkos T Middleton
Journal:  BMC Med       Date:  2016-11-03       Impact factor: 8.775

3.  Association between the extent of white matter damage and early cognitive impairment following acute ischemic stroke.

Authors:  Jian Li; Yong Zhao; Jinying Mao
Journal:  Exp Ther Med       Date:  2017-01-11       Impact factor: 2.447

4.  Depression and Apathy After Transient Ischemic Attack or Minor Stroke: Prevalence, Evolution and Predictors.

Authors:  Anna Carnes-Vendrell; Joan Deus; Jessica Molina-Seguin; Josep Pifarré; Francisco Purroy
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

5.  3D Cube FLAIR plus HyperSense compressed sensing is superior to 2D T2WI FLAIR scanning regarding image quality, spatial resolution, detection rate for cortical microinfarcts.

Authors:  Tiefang Liu; Yonghao Wang; Zhengyang Xu; Tao Wu; Xiao Zang; Meng Li; Jinfeng Li
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

6.  Progression of White Matter Hyperintensities Contributes to Lacunar Infarction.

Authors:  Xin Xu; Yuanyuan Gao; Renyuan Liu; Lai Qian; Yan Chen; Xiaoying Wang; Yun Xu
Journal:  Aging Dis       Date:  2018-06-01       Impact factor: 6.745

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.